ݺߣ

ݺߣShare a Scribd company logo

COVID 19 From A to Z

?
?
Goran Othman
Goran Othman

Understanding the basics on COV 19 including the last update on spreading and molecular structure of virions. It also includes information on pathological findings and treatments strategies

1 of 27
Download to read offline
COVID19 FROM A TO Z Goran Q. Othman Cell Biologist Erbil Polytechnic University 5th April 2020
The Origin of SARS-COV2
The Origin of SARS-COV2
COVID 19 From A to Z
The growing curve of confirmed cases per day Note the growth rate.. From tens per day in Feb to 100k per day in April
The growing curve of death cases since 30 days of 1st recorded
COVID 19 From A to Z
COVID 19 From A to Z
COVID 19 From A to Z
The Math. Of Epidemic: SIR Model
The Math. Of Epidemic: SIR Model
The Math. Of Epidemic: SIR Model
The Math. Of Epidemic: SIR Model
One of the controlling strategies is
COVID 19 From A to Z
COVID 19 From A to Z
Role of S glycoprotein and ACE2 in virus entry
COVID 19 From A to Z
COVID 19 From A to Z
COVID 19 From A to Z
Pathological Findings
Problems facing our immune system
COVID 19 From A to Z
Problems facing our immune system
COVID 19 From A to Z
Best targets for treatment..Blocking infection Kruse RL. Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China [version 2; peer review: 2 approved] F1000Research 2020, 9:72 (https://doi.org/10.12688/f1000research.22211.2)
Current Treatment Options ? Among the potential treatments for COVID-19 that are undergoing clinical trials to assess their safety and efficacy against the disease are: ? remdesivir (investigational) ? lopinavir/ritonavir (currently authorised as an anti-HIV medicine) ? chloroquine and hydroxychloroquine (currently authorised at national level as treatments against malaria and certain autoimmune diseases such as rheumatoid arthritis) ? systemic interferons and in particular interferon beta (currently authorised to treat diseases such as multiple sclerosis) ? monoclonal antibodies with activity against components of the immune system ? Ivermectin which is used as antiparasites especially related to skin

More Related Content

COVID 19 From A to Z

  • 1. COVID19 FROM A TO Z Goran Q. Othman Cell Biologist Erbil Polytechnic University 5th April 2020
  • 2. The Origin of SARS-COV2
  • 3. The Origin of SARS-COV2
  • 5. The growing curve of confirmed cases per day Note the growth rate.. From tens per day in Feb to 100k per day in April
  • 6. The growing curve of death cases since 30 days of 1st recorded
  • 10. The Math. Of Epidemic: SIR Model
  • 11. The Math. Of Epidemic: SIR Model
  • 12. The Math. Of Epidemic: SIR Model
  • 13. The Math. Of Epidemic: SIR Model
  • 14. One of the controlling strategies is
  • 17. Role of S glycoprotein and ACE2 in virus entry
  • 22. Problems facing our immune system
  • 24. Problems facing our immune system
  • 26. Best targets for treatment..Blocking infection Kruse RL. Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China [version 2; peer review: 2 approved] F1000Research 2020, 9:72 (https://doi.org/10.12688/f1000research.22211.2)
  • 27. Current Treatment Options ? Among the potential treatments for COVID-19 that are undergoing clinical trials to assess their safety and efficacy against the disease are: ? remdesivir (investigational) ? lopinavir/ritonavir (currently authorised as an anti-HIV medicine) ? chloroquine and hydroxychloroquine (currently authorised at national level as treatments against malaria and certain autoimmune diseases such as rheumatoid arthritis) ? systemic interferons and in particular interferon beta (currently authorised to treat diseases such as multiple sclerosis) ? monoclonal antibodies with activity against components of the immune system ? Ivermectin which is used as antiparasites especially related to skin